PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
686.38%
Net income growth of 686.38% while Healthcare median is zero at 0.00%. Walter Schloss would note a slight edge that could grow if sustained.
40.15%
D&A growth of 40.15% while Healthcare median is zero at 0.00%. Walter Schloss would question intangible or new expansions driving that cost difference.
-25.81%
Deferred tax shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see potential advantage if actual tax outflows do not spike.
310.60%
SBC growth of 310.60% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or staff additions causing more equity grants.
-602.02%
Working capital is shrinking yoy while Healthcare median is 0.00%. Seth Klarman would see an advantage if sales remain robust.
-138.18%
AR shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see an advantage in working capital if sales do not drop.
-144.96%
Inventory shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see a working capital edge if sales hold up.
-100.00%
AP shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see better immediate cost coverage if top-line remains intact.
-19.42%
Other WC usage shrinks yoy while Healthcare median is 0.00%. Seth Klarman would see an advantage if top-line is stable or growing.
-330.67%
Other non-cash items dropping yoy while Healthcare median is -6.64%. Seth Klarman would see a short-term advantage if real fundamentals remain intact.
-12852.71%
Negative CFO growth while Healthcare median is -12.48%. Seth Klarman would suspect a firm-specific operational weakness if peers maintain growth.
18.60%
CapEx growth of 18.60% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or upgrades behind the difference.
649.13%
Acquisition growth of 649.13% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or partial deals fueling that difference.
87.28%
Purchases growth of 87.28% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or new strategic positions driving the difference.
18.93%
Proceeds growth of 18.93% while Healthcare median is zero at 0.00%. Walter Schloss would question if expansions or certain maturities are driving this difference.
-973.07%
We reduce “other investing” yoy while Healthcare median is 0.00%. Seth Klarman would see a potential advantage in preserving cash if top-line growth is not harmed.
62.56%
Investing flow of 62.56% while Healthcare median is zero at 0.00%. Walter Schloss would question expansions or deals prompting that difference.
-43.37%
Debt repayment yoy declines while Healthcare median is 0.00%. Seth Klarman fears increased leverage if expansions do not yield quick returns.
-100.00%
We reduce issuance yoy while Healthcare median is 0.00%. Seth Klarman might see an advantage in preserving per-share value unless expansions are neglected.
No Data
No Data available this quarter, please select a different quarter.